A new antiviral drug that induces mutations in the genetic material of influenza virus is highly effective in treating influenza infection in animals and human airway tissue and could be a groundbreaking advance in influenza therapy, according to a study by the Institute for Biomedical Sciences at Georgia State University.
The antiviral drug blocks RNA polymerase, the enzyme that plays a central role in replicating the genome of influenza virus, causing mutations in the viral genome. If enough mutations occur, the genome becomes nonfunctional and the virus cannot replicate. The findings were published online on Oct. 23 in Science Translational Medicine.
“The compound is highly efficacious against influenza,” said Dr. Richard Plemper, senior author of the study and a professor in the Institute for Biomedical Sciences. “It’s orally available, it’s broad spectrum against all influenza virus strains tested, and most important it establishes a high barrier against viral escape from inhibition.”
Influenza, caused by a contagious respiratory virus, is characterized by fever, cough, headache, muscle and joint pain, severe malaise, sore throat and sometimes gastrointestinal symptoms. Patients in higher risk groups, such as older adults and individuals with compromised immune systems, frequently require hospitalization. Each year, seasonal influenza results in 30,000 to 80,000 fatalities in the United States. The seasonal flu vaccine is only moderately effective, and licensed antivirals are compromised by rapidly emerging viral resistance to the drugs.
In the study, the new antiviral drug was tested in ferrets, the most informative animal model for human influenza disease, against various strains that include seasonal and pandemic viruses, such as the swine-origin influenza virus responsible for a 2009 pandemic. The researchers found that the antiviral drug efficiently inhibited replication of all of these strains. Virus burden dropped rapidly after treatment, and the duration of fever was significantly shorter in treated ferrets than in control animals that did not receive the drug.
“We think that the next generation of influenza antiviral drugs must not only be efficacious and safe, but also address the resistance problem,” said Dr. Mart Toots, first author of the study and a research assistant professor associated with Dr. Plemper’s lab in the Institute for Biomedical Sciences.
That is where the new drug comes in. Through a combination of conventional and ultra-deep sequencing, Toots has demonstrated in collaboration with Dr. Alex Greninger at the University of Washington that it is very challenging for the virus to find a viable way to avoid the compound.
“We have not identified specific resistance mutations yet and are confident to say that the genetic barrier against viral resistance is high,” Plemper said. “We believe that this compound has high clinical potential as a next-generation influenza drug that combines key antiviral features.”
Learn more: Biomedical Sciences Researchers Demonstrate That New Antiviral Drug Effectively Treats Influenza
The Latest on: Influenza
[google_news title=”” keyword=”influenza” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Influenza
- What’s Going Around: Scarlet fever, influenza, upper respiratory infections, stomach viruses, allergieson April 26, 2024 at 6:51 pm
Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local doctors and hospitals.
- Can You Get Bird Flu From Eggs and Milk? Everything to Know About Avian Influenzaon April 26, 2024 at 12:12 pm
The FDA says 20% of retail milk samples have tested positive for bird flu “viral fragments.” We asked a virologist and bird veterinarian what that means for dairy consumers.
- FDA finds traces of H5N1 bird flu viruses in grocery store milk but says pasteurized dairy products are still safeon April 26, 2024 at 10:39 am
The US Food and Drug Administration said Tuesday that it had detected viral particles of H5N1 avian influenza in milk purchased at grocery stores, but the agency says it still believes that the milk ...
- Mayo Clinic virologist offers perspective on avian influenza outbreakon April 26, 2024 at 9:34 am
Health officials around the globe, including the Centers for Disease Control and Prevention and the European Centre for Disease Control and Prevention, are monitoring the ongoing avian influenza ...
- Nationals being mindful with Ruiz in his return from influenzaon April 25, 2024 at 5:47 pm
Sidelined for 13 team games, Keibert Ruiz wanted to get back behind the plate. The starting catcher was wiped out, though. At the beginning of the Nationals' three-city West Coast road trip, Ruiz came ...
- Flu shot fatigue: influenza vaccination rates in R.I. continue to fall post-pandemicon April 25, 2024 at 2:30 am
Chalk it up to shot sickness, or maybe just an inflated sense of immunity. Either way, fewer Rhode Island adults rolled up their sleeves for a flu shot this year, though the state remains a national ...
- Dairy and Veterinary Experts from Iowa State to Give Update on Avian Influenza in Ruminantson April 23, 2024 at 1:38 pm
AMES, Iowa – The Iowa State University Extension and Outreach dairy team will host a second “virtual chat” to discuss the latest information on how Highly Pathogenic Avian Influenza (HPAI) is ...
- Influenza is considered the biggest pandemic threaton April 23, 2024 at 9:30 am
Influenza is viewed by infectious disease specialists as the pathogen with the highest pandemic potential, according to findings unveiled at a major global congress in Barcelona.
- Is There a Vaccine for H5N1 Influenza?on April 22, 2024 at 2:31 pm
On the heels of a multi-state outbreak of highly pathogenic avian influenza A (H5N1) in dairy cows, experts told MedPage Today that a trio of H5N1 vaccines for humans has already been developed and ...
- New study rates influenza as the top pandemic threat, here’s whyon April 21, 2024 at 6:50 am
Other highly ranked pathogens included "Disease X", and the viruses responsible for SARS, SARS-CoV-2, and Ebola.
via Bing News